| Name | Title | Contact Details |
|---|
Our mission is to transform lives. To give you the tools that empower you to be in the driver`s sear of your own health, to turn your thoughts into things, and dream into reality.
LifeSync Corporation is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Egg Donation & Gestational Surrogacy services. Since 1996 ConceiveAbilities has professionally partnered with countless physicians and intended parents around the globe to help build families via third party reproduction. More than 20 years navigating the infertility industry has positioned ConceiveAbilities as the best partner to provide an unmatched level of service. Our unique and extensive experience and a reputation built on unparalleled service, knowledge and communication, allows us to cultivate excellent professional relationships with doctors and clinics, in addition to providing our clients, egg donors and surrogates with consistently solid service. Here at ConceiveAbilities, we believe that individuals and couples who have the desire to pursue a family, deserve the best support and resources possible. If you are committed to excellence and would like to join our team of enthusiastic dream-makers, we invite you to browse our webpage highlighting open positions among ConceiveAbilities` multiple locations.
Marpai helps people live better, stay stronger, and spend less on healthcare by using the most advanced artificial intelligence capabilities to empower greater health outcomes and reduced costs. We bring the world`s first SMART Health Plan Services System which enables health plan members to do things they could never do before. Avert and reduce chronic illness and costly procedures with early intervention. Save money with top quality in-network providers and telehealth. Simplify complex care with experts that guide the best journey. Avoid unnecessary ER visits, procedures and re-admissions. And, use the Marpai SMART app to book appointments, access telehealth, save money and more.
KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.